|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Migraine | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Migraine Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Headache Disorders | |||||
| Headache Disorders, Primary | |||||
| Nervous System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| DP-VPA | |||||
| DP-VPA Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| D-Pharm Ltd. | |||||